학술논문
Correction: Benefit of prompt initiation of single-inhaler fluticasone furoate, umeclidinium, and vilanterol (FF/UMEC/VI) in patients with COPD in England following an exacerbation: a retrospective cohort study.
Document Type
Article
Author
Source
Subject
*DISEASE exacerbation
*COHORT analysis
*FLUTICASONE
*CHRONIC obstructive pulmonary disease
*RETROSPECTIVE studies
*
*
*
*
Language
ISSN
1465-9921
Abstract
This correction notice addresses errors in a study published in Respiratory Research regarding the benefits of prompt initiation of a specific inhaler for patients with COPD in England. The errors were related to the costs associated with the treatment and impacted certain statements in the "Results," "Discussion," and "Conclusions" sections of the article. The corrected information indicates that prompt initiators had numerically lower all-cause total costs and similar COPD-related costs compared to delayed initiators. The authors apologize for the discrepancies and any inconvenience caused. [Extracted from the article]